This article is more than 5 years old. Information may no longer be current.
VIDEO: Expert highlights noninvasive testing for IBD and IBS, other gastroenterology updates
Click Here to Manage Email Alerts
WASHINGTON — John I. Allen, MD, MBA, clinical chief of digestive diseases at Yale University School of Medicine, highlighted six recently published studies for an update of gastroenterology and hepatology here at the annual American College of Physicians Internal Medicine Meeting.
He discussed a study of noninvasive testing of irritable bowel syndrome and inflammatory bowel disease.
"As you know, irritable bowel syndrome is very common," Allen said in the interview. "About 20% of adults have it and present to your office. Often the question, particularly with those that have diarrhea, is 'could this be inflammatory bowel disease?' In this well-done meta-analysis of 12 studies, Bill Chey's group out of the University of Michigan found that if the C-reactive protein was less than 0.5 and the fecal calprotectin was less than 40, this discriminated very well between IBS and IBD.”
He also highlighted colon-related studies on reference pricing for screening colonoscopies, family history and colon cancer, fecal occult blood testing after a negative colonoscopy, screening efficacy of capsule endoscopy and fecal microbiota transplant for C. difficile infections.